Skip to content
The Policy VaultThe Policy Vault

Ibtrozi (taletrectinib capsules – Nuvation Bio) — Cigna

Non-small cell lung cancer (locally advanced or metastatic, ROS1-positive)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has locally advanced or metastatic disease
  • Patient has ROS1-positive non-small cell lung cancer
  • The mutation was detected by an approved test

Approval duration

1 year